3D Kinematic Assessment of the Human Knee During Physical and Daily Life Activities
NCT ID: NCT01661647
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
10 participants
INTERVENTIONAL
2025-07-02
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: A new system using personalized 3D bone imaging and a percutaneous bone fixation device that can be used under local anesthesiaallows for precise and reproducible assessment of 3D knee kinematics during physical and daily life activities.
Objectives :
* To study human knee 3D kinematics during dynamic activities using a novel minimally invasive measuring system
* Investigate the correlations between standard clinical knee laxity tests and measured 3D knee kinematics during dynamic activities
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Minimally Invasive Three-dimensional Knee Kinematic Assessment and Surgical Guidance Using Ultrasonic Rigid Registration
NCT01674816
Gait, Stair Climbing and Postural Stability in Knee Osteoarthritis Patients After Hyaluronic Acid Injection
NCT02063373
Evaluation of Bone Mineral Density Changes Using Two Tibial Base Plate Designs in Primary Total Knee Arthroplasty in Young Patient
NCT03970460
Navigation System for in Vivo Measurement of the Kinematics of the Knee
NCT02467699
A Prospective Randomized Trial Using Roentgen Stereophotogrammetric Analysis of the Advance Medial Pivot Knee
NCT00405470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3D knee kinematic assessment
3D knee kinematic assessment under local anesthesia
3D knee kinematic assessment under local anesthesia
3D knee kinematic assessment under local anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D knee kinematic assessment under local anesthesia
3D knee kinematic assessment under local anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe swelling of the knee
* Knee flexion contracture
* Knee flexion less than 120 degrees
* Gross limping
* Inability to perform the various motor tasks required by the study protocol
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eiffel Medtech
INDUSTRY
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric Lavoie, MD MSc FRCSC
Role: PRINCIPAL_INVESTIGATOR
CHUM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUM
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Frédéric Lavoie, MD MSc FRCSC
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE 12.005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.